10 found
Sort by:
Disambiguations:
Rob Reuzel [9]Rob P. B. Reuzel [1]
  1. Margriet Moret-Hartman, Rob Reuzel, John Grin & Gert Jan van der Wilt (2008). Participatory Workshops Are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-Beta for Multiple Sclerosis. [REVIEW] Health Care Analysis 16 (2):161-175.
    A possible explanation for policy implementation failure is that the views of the policy’s target groups are insufficiently taken into account during policy development. It has been argued that involving these groups in an interactive process of policy development could improve this. We analysed a project in which several target populations participated in workshops aimed to optimise the utilisation of an expensive novel drug (interferon beta) for patients with Multiple Sclerosis. All participants seemed to agree on the appropriateness of establishing (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  2. Wija Oortwijn, Rob Reuzel & Michael Decker (2004). Introduction. Poiesis and Praxis 2 (s 2-3):97-101.
    No categories
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  3. Rob Reuzel (2004). Interactive Technology Assessment of Paediatric Cochlear Implantation. Poiesis and Praxis 2 (s 2-3):119-137.
    Interactive technology assessment is a novel approach to evaluating (health) technology, which philosophically draws from the works of Rawls and Habermas. That is, it seeks to organise a practical setting for discursive ethics in order to find a legitimate basis for policy to be pursued when the technology under scrutiny features a moral controversy. Interactive technology assessment involves a cycle of interviews with all stakeholders, who are explicitly asked to respond (anonymously) to the concerns and issues raised by other participants. (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  4. Rob Reuzel, Wija Oortwijn, Michael Decker, Christian Clausen, Pedro Gallo, John Grin, Armin Grunwald, Leo Hennen, Gert Wilt & Yutaka Yoshinaka (2004). Ethics and HTA: Some Lessons and Challenges for the Future. Poiesis and Praxis 2 (s 2-3):247-256.
    No categories
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  5. Rob Reuzel, Wija Oortwijn, Michael Decker, Christian Clausen, Pedro Gallo, John Grin, Armin Grunwald, Leo Hennen, GertJan van der Wilt & Yutaka Yoshinaka (2004). Ethics and HTA: Some Lessons and Challenges for the Future. Poiesis and Praxis: International Journal of Technology Assessment and Ethics of Science 2 (2):247-256.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  6. Rob Reuzel (2003). Short Literature Notices. Medicine, Health Care and Philosophy 6:327-336.
    No categories
    Direct download  
     
    My bibliography  
     
    Export citation  
  7. Rob Reuzel, Gert Jan van Der Wilt, Pieter Vries Robbdeé & Henk ten Have (2001). A View From the Netherlands: Ethics as Interactive Evaluation. Cambridge Quarterly of Healthcare Ethics 10 (1):110-114.
    Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  8. Rob Reuzel, Gert Jan Van der Wilt, Pieter de Vries Robbé & Henk ten Have (2001). A View From the Netherlands: Ethics as Interactive Evaluation. Cambridge Quarterly of Healthcare Ethics 10 (1):110-114.
    From 1991 to 1994 the Dutch Health Insurance Council financed research on Extracorporeal Membrane Oxygenation (ECMO). This is a technique for providing cardiopulmonary bypass to patients with pulmonary and/or cardiac failure. Most often, these patients are premature neonates. During ECMO, blood is drained from the right atrium, pumped along a membrane where gas exchange takes place, and then redirected to the aorta. To prevent blood clotting, heparin is added. However, with the heparin added, the risk of hemorrhage is considerably increased. (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  9. Gert Jan van der Wilt, Rob Reuzel & H. David Banta (2000). The Ethics of Assessing Health Technologies. Theoretical Medicine and Bioethics 21 (1):101-113.
    Health technology assessment (HTA) consists of thesystematic study of the consequences of theintroduction or continued use of the technology in aparticular context, with the explicit objective toarrive at a judgment of the value or merit of thetechnology. Ideally, it is aimed at assessing allaspects of a given technology or group oftechnologies, including non-technical, e.g.socio-ethical, aspects. However, methods for assessingsocio-ethical implications of health technology arerelatively undeveloped and few mechanisms exist totake action based on the results of such evaluations.Still, the examples (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  10. Rob P. B. Reuzel, Gert-Jan van Der Wilt, Henk A. M. J. ten Have & Pieter F. de Vries Robbé (1999). Reducing Normative Bias in Health Technology Assessment: Interactive Evaluation and Casuistry. Medicine, Health Care and Philosophy 2 (3):255-263.
    Health technology assessment (HTA) is often biased in the sense that it neglects relevant perspectives on the technology in question. To incorporate different perspectives in HTA, we should pursue agreement about what are relevant, plausible, and feasible research questions; interactive technology assessment (iTA) might be suitable for this goal. In this way a kind of procedural ethics is established. Currently, ethics too often is focussed on the application of general principles, which leaves a lot of confusion as to what really (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation